BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND RUNX1T1, ENSG00000079102, 862 AND Prognosis
19 results:

  • 1. PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study.
    Zhong Y; Cai C; Chen T; Gui H; Chen C; Deng J; Yang M; Yu B; Song Y; Wang T; Chen Y; Shi H; Xie D; Chen C; She Y
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):521-534. PubMed ID: 37725128
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Preoperative CT findings and prognosis of pulmonary sarcomatoid carcinoma: comparison with conventional NSCLC of similar tumor size.
    Tang W; Wen C; Pei Y; Wu Z; Zhong J; Peng J; Zhong J
    BMC Med Imaging; 2023 Aug; 23(1):105. PubMed ID: 37580691
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction of a genomic instability-derived predictive prognostic signature for non-small cell lung cancer patients.
    Li W; Wu H; Xu J
    Cancer Genet; 2023 Nov; 278-279():24-37. PubMed ID: 37579716
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
    Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L;
    Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MicroRNA-340 and MicroRNA-450b-5p: Plasma Biomarkers for Detection of Non-Small-Cell lung cancer.
    Wu Y; Jing H; Zhang J
    J Environ Public Health; 2022; 2022():8024700. PubMed ID: 36531335
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis.
    Zhang D; Liu J; Zheng M; Meng C; Liao J
    World J Surg Oncol; 2022 Oct; 20(1):351. PubMed ID: 36309698
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Construction of a nomogram model for predicting 2-year survival rate of small cell lung cancer based on more comprehensive variables].
    Wei LJ; Hou Q; Yao NN; Liang Y; Cao X; Sun BC; Li HW; Liu JT; Xu SM; Cao J
    Zhonghua Yi Xue Za Zhi; 2022 May; 102(17):1283-1289. PubMed ID: 35488697
    [No Abstract]    [Full Text] [Related]  

  • 8. Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer.
    Stares M; Ding TE; Stratton C; Thomson F; Baxter M; Cagney H; Cumming K; Swan A; Ross F; Barrie C; Maclennan K; Campbell S; Evans T; Tufail A; Harrow S; Lord H; Laird B; MacKean M; Phillips I
    ESMO Open; 2022 Apr; 7(2):100445. PubMed ID: 35398717
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
    Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
    Support Care Cancer; 2022 May; 30(5):4505-4514. PubMed ID: 35113225
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
    Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
    Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Meta-analysis of association between CT-based features and tumor spread through air spaces in lung adenocarcinoma.
    Yin Q; Wang H; Cui H; Wang W; Yang G; Qie P; Xun X; Han S; Liu H
    J Cardiothorac Surg; 2020 Sep; 15(1):243. PubMed ID: 32912289
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With cancer Starting Chemotherapy.
    Elfiky AA; Pany MJ; Parikh RB; Obermeyer Z
    JAMA Netw Open; 2018 Jul; 1(3):e180926. PubMed ID: 30646043
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
    Hoda MA; Dong Y; Rozsas A; Klikovits T; Laszlo V; Ghanim B; Stockhammer P; Ozsvar J; Jakopovic M; Samarzija M; Brcic L; Bendek M; Szirtes I; Reid G; Kirschner MB; Kao SC; Opitz I; Weder W; Frauenfelder T; Nguyen-Kim TD; Aigner C; Klepetko W; van Zandwijk N; Berger W; Dome B; Grusch M; Hegedus B
    Eur J Cancer; 2016 Aug; 63():64-73. PubMed ID: 27288871
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
    Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM
    Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
    Zhao J; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review.
    Chen S; Flower A; Ritchie A; Liu J; Molassiotis A; Yu H; Lewith G
    Lung Cancer; 2010 May; 68(2):137-45. PubMed ID: 20015572
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Bronchioloalveolar carcinoma in Spain: a rare and different form of lung cancer].
    López Encuentra A; Pozo Rodríguez F; Martín de Nicolás JL; Villena V; Sayas Catalán J;
    Arch Bronconeumol; 2006 Aug; 42(8):399-403. PubMed ID: 16948993
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
    Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.